News 2023


Wenger Plattner advises Bachem on strategic framework agreement

On 3 March 2023, Bachem (SIX: BANB) announced the signing of a new framework agreement with an undisclosed customer to provide large volumes of peptides following a joint development project. The agreement covers a committed volume at an equivalent value of over CHF 500 million for the five-year period of 2027-2031, with significant upside potential.

Wenger Plattner (Dr. Tobias Meili) advised Bachem on the terms of the framework agreement and regarding aspects of SIX Listing Rules.

> Back to the overview